Future Truths: Inevitable and Inspiring
The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.
Summary of CY2022 Advance Notice Summary Part II
CMS proposes Stars rating changes, revises MA plan definitions, calls for new COVID-19 vaccination measures, and more.
The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.
How Market Trends and Dynamics are Impacting Insurers' Bottom Lines
An analysis of market profitability and capitalization trends as well as new insights into insurers' recent claims experiences.
Part 4: State-by-State Market Impact
Six factors that dictate the kind of health coverage people who've lost their jobs want next.
Healthcare Cost and Utilization During COVID-19
An analysis of what claim payments and delays may look like later this year.
An analysis of annual premiums by federal poverty level.
Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
Why a focus on the provider is needed to achieve 4 or 5 Stars.
Based on our analysis recently featured in the Wall Street Journal, the prevalence of no cost bronze coverage has increased significantly for 2018.
